BioScience Health Innovations, Inc.
NOTR
$9.01
-$0.99-9.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 610.20K | 573.00K | 384.20K | 277.60K | 303.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 610.20K | 573.00K | 384.20K | 277.60K | 303.60K |
| Cost of Revenue | 271.20K | 148.20K | 73.80K | 42.80K | 67.10K |
| Gross Profit | 339.00K | 424.70K | 310.40K | 234.80K | 236.50K |
| SG&A Expenses | 329.10K | 368.50K | 236.20K | 288.10K | 274.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 600.30K | 516.80K | 309.90K | 331.00K | 342.00K |
| Operating Income | 10.00K | 56.20K | 74.20K | -53.40K | -38.40K |
| Income Before Tax | 10.00K | 56.20K | 74.20K | -53.40K | -38.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.00K | 56.20K | 74.20K | -53.40K | -38.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.00K | 56.20K | 74.20K | -53.40K | -38.40K |
| EBIT | 10.00K | 56.20K | 74.20K | -53.40K | -38.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 42.65M | 42.09M | 41.60M | 41.39M | 40.78M |
| Average Diluted Shares Outstanding | 44.33M | 42.09M | 41.60M | 41.39M | 40.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |